Donald Harn, professor of infectious diseases and Georgia Research Alliance Distinguished Investigator, studies inflammation-based diseases as well as developing new vaccines and reagents. Harn is the founder and CEO of EnduraVax LLC, a startup company commercializing a hydrogel vaccine delivery mechanism that greatly improves vaccine efficacy. Read More.